Wuxi apptec: postponement and change of fund use of some A-share IPO projects
Cailian news agency, Dec. 31, Wuxi apptec announced that the company considered and approved the proposal on the extension of some A-share initial raising investment projects and the change of fund use, which still needs to be submitted to the general meeting of shareholders of the company for deliberation. The company plans to change the implementation subject and location of the "Suzhou drug safety evaluation center expansion project", that is, the purpose of the raised funds will be changed to "Suzhou and Nantong drug safety evaluation center expansion project", and the time of scheduled availability will be extended.
This text is a result of machine translation.
Related companies：
Briefing May 18, 2022 09:28 AM
· Technology
97 shares were financed to buy more than 100 million yuan, and BYD was the first to buy 1.113 billion yuan
In-depth
May 02, 2022 07:50 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Apr 18, 2022 09:14 PM
Briefing Mar 13, 2022 08:49 PM
· Financials
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Briefing Mar 12, 2022 06:09 AM
· Financials
The financial data in February was less than expected, and experts said it was necessary to reduce the reserve requirement and interest rate
Healthcare
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Mar 31, 2021 11:38 AM
Briefing Mar 09, 2022 05:49 PM
Tianci materials: the net profit in the first two months increased by about 470% year-on-year
Briefing Feb 15, 2022 12:19 PM
· Financials
For half a day, the main funds increased their positions in the power equipment sector and sold off bank stocks
See more
Read next
In-depth
Technology
Exclusive Interview with Liu Di, Managing Director of Peakview Capital
Yesterday 12:51 PM
In-depth
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.